KAI Pharmaceuticals Director of Finance Salaries in Albuquerque, NM | Comparably
KAI Pharmaceuticals discovers and develops novel therapeutics for cardiovascular diseases, kidney diseases and pain. read more
EMPLOYEE
PARTICIPANTS
3
TOTAL
RATINGS
89

KAI Pharmaceuticals Director of Finance Salaries in Albuquerque, NM

The average KAI Pharmaceuticals Director of Finance in Albuquerque, NM earns an estimated $139,968 annually. KAI Pharmaceuticals' Director of Finance compensation is $22,048 less than the US average for a Director of Finance.

In Albuquerque, NM, The Finance Department at KAI Pharmaceuticals earns $14,945 more on average than the Customer Support Department.

Last updated 5 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$139,968
Average Compensation
$139,968
avg. base

Director of Finance Salaries at KAI Pharmaceuticals

In Albuquerque, NM, Directors of Finance earn $19,656 more than Business Analysts.

Business Analyst
$120k*
Accounting Manager
$116k*
Senior Accountant
$93k*
Financial Analyst
$87k*
Accountant
$67k*
* estimated salary

Compensation at KAI Pharmaceuticals by Department

In Albuquerque, NM, The Finance Department averages $14,945 more than the Customer Support Department, and $19,797 less than the IT Department

IT
$100,520 Avg. total comp.
+$20k
Finance
$80,723 Avg. total comp.
Customer Support
$65,778 Avg. total comp.
-$15k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to KAI Pharmaceuticals reported making $176,135, while the average male Director of Finance at similar sized companies reported making $188,131.

Director of Finance Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Director of Finance at companies similar size to KAI Pharmaceuticals reported making $193,239, while the average Native American Director of Finance at similar sized companies reported making $145,000.

How Directors of Finance at KAI Pharmaceuticals Rate Their Compensation

The majority of Directors of Finance at KAI Pharmaceuticals believe they're compensated fairly. 100% of Directors of Finance at KAI Pharmaceuticals say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at KAI Pharmaceuticals

×
Rate your company